Tagged with UAE,

UAE Zeina Sfeir Lahoud of Biologix, a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East and North Africa (MENA) region, highlights important recent developments for the company – including a groundbreaking “value management agreement” in the UAE – and her hopes for…

UAE Dr Ibtesam Al Bastaki, director of healthcare investment at the Dubai Health Authority (DHA) describes how healthcare investment is flowing into the Emirate via both pure investments and public-private partnerships (PPPs) and the impact of a range of other topics including screening programs, digital health, and healthcare tourism.   PPP…

UAE Tarek Thaher of MS Pharma, a leading generics firm in the Middle East and Africa, describes the benefits of manufacturing localisation in the UAE, his excitement about the firm’s growth trajectory based on a host of upcoming product launches, and its moves into the biosimilars space.   All in all,…

UAE An overview of the evolution of healthcare infrastructure, professionals, and spending in Dubai. Taken from the Dubai Health Authority’s Investment Guide 2023, the below charts show the rapid growth of the healthcare ecosystem in the Emirate and hint at its future prospects for further development.   made with Visme Infographic…

UAE Marwa Soliman of blood gas testing pioneer Radiometer explains how the company’s operations have developed in the MEA region, growing awareness of the importance of point-of-care diagnostics post-COVID, and how she aims to make sure that patients’ lives come first in all of Radiometer’s work.   COVID made healthcare regulators…

UAE Ramy Koussa shares the passion and vision of focused women’s health player Organon in the MENAT region, how the organisation has adapted and improved to better serve women in the region in its first two years of operation as an independent company, and why multi-stakeholder partnerships and collaboration are crucial…

UAE Amr Seif outlines Astellas’ progress into becoming a focused oncology speciality player in the Middle East and Africa, in line with the company’s global Corporate Strategic Plan 2021 (CSP2021). He also touches on key market trends in MEA, including regulatory developments, the rise of private insurance, and the growing importance…

UAE Tabuk Pharmaceuticals is a Saudi success story, now established as one of the GCC region’s leading private pharmaceutical companies. Gulf Manager Ossama Salah Ramadan explains what attracted him to the firm, his current strategic objectives in line with the company’s global growth goals, and some of the key local trends…

UAE 16-year Gilead veteran, Vítor Papão, recently left Europe to take on a new role within the company as general manager of the vast Middle East & Russia cluster. He discusses the particularities of the region, and the partnerships and initiatives Gilead is actively pursuing with local stakeholders.   We have…

UAE PhRMA MEA’s Samir Khalil highlights some of the key trends at play across the Middle East and Africa’s dynamic and fast-changing pharmaceutical ecosystem, including several wide-ranging national health transformation plans, the move towards health technology assessment (HTA), and the importance of maintaining robust intellectual property (IP) protection.   We can…

UAE Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, discusses the park’s key milestones and plans for the future, the positive changes in the UAE’s regulatory landscape since COVID, and his excitement about digital health trends and technologies.   At Dubai Science Park, we are proud to play a…

UAE AHK UAE CEO Oliver Oehms gives an overview of German healthcare investment in the Emirates, how the Chamber assists German firms in adjusting to the rapid pace of reform in the UAE, and his hopes for the future of German-Emirati economic cooperation more broadly.   We are confident that the…